Pages that link to "Q33965358"
Jump to navigation
Jump to search
The following pages link to The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase (Q33965358):
Displaying 50 items.
- Roles of tyrosine phosphorylation and cleavage of protein kinase Cdelta in its protective effect against tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis (Q24298245) (← links)
- From death receptor to reactive oxygen species and c-Jun N-terminal protein kinase: the receptor-interacting protein 1 odyssey (Q24299330) (← links)
- Arf and Rho GAP adapter protein ARAP1 participates in the mobilization of TRAIL-R1/DR4 to the plasma membrane (Q24305255) (← links)
- Luteolin, a flavonoid with potential for cancer prevention and therapy (Q24652632) (← links)
- Onto better TRAILs for cancer treatment (Q26768160) (← links)
- Necroptosis: molecular signalling and translational implications (Q27015896) (← links)
- RIP1, a kinase on the crossroads of a cell's decision to live or die (Q28288337) (← links)
- TRAIL activates JNK and NF-κB through RIP1-dependent and -independent pathways (Q28384960) (← links)
- Tumour necrosis factor receptor 1 mediates endoplasmic reticulum stress-induced activation of the MAP kinase JNK (Q28508892) (← links)
- A set of NF-κB-regulated microRNAs induces acquired TRAIL resistance in lung cancer. (Q30361915) (← links)
- TAK1 is required for survival of mouse fibroblasts treated with TRAIL, and does so by NF-kappaB dependent induction of cFLIPL. (Q33523025) (← links)
- Retaining MKP1 expression and attenuating JNK-mediated apoptosis by RIP1 for cisplatin resistance through miR-940 inhibition (Q33576820) (← links)
- Receptor-interacting protein shuttles between cell death and survival signaling pathways (Q33623823) (← links)
- The linear ubiquitin chain assembly complex regulates TRAIL-induced gene activation and cell death (Q33625907) (← links)
- Acquired activation of the Akt/cyclooxygenase-2/Mcl-1 pathway renders lung cancer cells resistant to apoptosis (Q33714703) (← links)
- Targeting a novel N-terminal epitope of death receptor 5 triggers tumor cell death (Q33726537) (← links)
- RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3 (Q33798944) (← links)
- Cardiac glycosides inhibit TNF-alpha/NF-kappaB signaling by blocking recruitment of TNF receptor-associated death domain to the TNF receptor (Q33868825) (← links)
- Soluble TRAIL in normal pregnancy and acute pyelonephritis: a potential explanation for the susceptibility of pregnant women to microbial products and infection (Q33910907) (← links)
- DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas. (Q33939106) (← links)
- New insights into apoptosis signaling by Apo2L/TRAIL. (Q34022690) (← links)
- c-Cbl acts as a mediator of Src-induced activation of the PI3K-Akt signal transduction pathway during TRAIL treatment (Q34250032) (← links)
- Tumor necrosis factor-related apoptosis-inducing ligand induces caspase-dependent interleukin-8 expression and apoptosis in human astroglioma cells (Q34272896) (← links)
- A signaling pathway consisting of miR-551b, catalase and MUC1 contributes to acquired apoptosis resistance and chemoresistance (Q34434902) (← links)
- The role of TRADD in TRAIL‐induced apoptosis and signaling (Q34682495) (← links)
- In TNF-stimulated cells, RIPK1 promotes cell survival by stabilizing TRAF2 and cIAP1, which limits induction of non-canonical NF-kappaB and activation of caspase-8 (Q34787151) (← links)
- RIP kinases: key decision makers in cell death and innate immunity (Q34924104) (← links)
- TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality. (Q35009467) (← links)
- Epidermal Growth Factor Receptor-mediated Tissue Transglutaminase Overexpression Couples Acquired Tumor Necrosis Factor-related Apoptosis-inducing Ligand Resistance and Migration through c-FLIP and MMP-9 Proteins in Lung Cancer Cells (Q35065126) (← links)
- Apoptotic signaling cascades. (Q35092230) (← links)
- Synthesis and SAR studies of novel 6,7,8-substituted 4-substituted benzyloxyquinolin-2(1H)-one derivatives for anticancer activity (Q35111443) (← links)
- The TRAIL to viral pathogenesis: the good, the bad and the ugly (Q35146349) (← links)
- TRAF2 exerts its antiapoptotic effect by regulating the expression of Krüppel-like factor LKLF (Q35169970) (← links)
- Genes and genomics of autoimmune inflammation: from Rel to TRAIL. (Q35176314) (← links)
- Clinical implications of the tumor necrosis factor family in benign and malignant hematologic disorders (Q35184335) (← links)
- TRAIL, Bim, and thymic-negative selection (Q35624736) (← links)
- Modulation of TRAIL signaling complex. (Q35756863) (← links)
- TRAIL and NFkappaB signaling--a complex relationship (Q35756866) (← links)
- TRAIL and malignant glioma. (Q35756919) (← links)
- A20 ubiquitin ligase-mediated polyubiquitination of RIP1 inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastoma (Q35967192) (← links)
- Regulation in the targeting of TRAIL receptor 1 to cell surface via GODZ for TRAIL sensitivity in tumor cells (Q36028494) (← links)
- RIP1 Cleavage in the Kinase Domain Regulates TRAIL-Induced NF-κB Activation and Lymphoma Survival (Q36033375) (← links)
- Intracellular signals and events activated by cytokines of the tumor necrosis factor superfamily: From simple paradigms to complex mechanisms. (Q36597952) (← links)
- The role of TRADD in death receptor signaling (Q36920268) (← links)
- Cells surviving fractional killing by TRAIL exhibit transient but sustainable resistance and inflammatory phenotypes (Q37003894) (← links)
- Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy (Q37071019) (← links)
- RIP1 potentiates BPDE-induced transformation in human bronchial epithelial cells through catalase-mediated suppression of excessive reactive oxygen species (Q37151621) (← links)
- Differential activation of JNK1 isoforms by TRAIL receptors modulate apoptosis of colon cancer cell lines. (Q37222625) (← links)
- Akt-mediated eminent expression of c-FLIP and Mcl-1 confers acquired resistance to TRAIL-induced cytotoxicity to lung cancer cells (Q37273453) (← links)
- Repression of NF-kappaB and activation of AP-1 enhance apoptosis in prostate cancer cells (Q37275591) (← links)